Market Overview

7 Biggest Price Target Changes For Wednesday

Share:
  • Credit Suisse raised the price target for salesforce.com, inc. (NYSE: CRM) from $150 to $155. salesforce.com shares closed at $126.88 on Tuesday.
  • Morgan Stanley boosted the price target for WellCare Health Plans, Inc. (NYSE: WCG) from $228 to $237. WellCare Health shares closed at $221.15 on Tuesday.
  • Barclays increased Palo Alto Networks, Inc. (NYSE: PANW) price target from $206 to $235. Palo Alto shares closed at $207.85 on Tuesday.
  • Baird boosted Ulta Beauty, Inc. (NASDAQ: ULTA) price target from $265 to $290. Ulta Beauty shares closed at $253.69 on Tuesday.
  • SunTrust Robinson Humphrey cut DXC Technology Company (NYSE: DXC) price target from $115 to $105. DXC Technology shares closed at $89.99 on Tuesday.
  • Argus raised the price target on Costco Wholesale Corporation (NASDAQ: COST) from $200 to $220. Costco shares closed at $196.74 on Tuesday.
  • Credit Suisse lowered the price target for AbbVie Inc. (NYSE: ABBV) from $104 to $89. AbbVie shares closed at $99.47 on Tuesday.

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

 

Related Articles (COST + ABBV)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
TOLGoldman SachsInitiates Coverage On42.0
KBHGoldman SachsInitiates Coverage On36.0
YEXTSunTrust Robinson HumphreyMaintains28.0
LHCGSunTrust Robinson HumphreyMaintains160.0
DLRSunTrust Robinson HumphreyMaintains140.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Italy ETF Walloped As 'Quitaly' Speculation Intensifies

Morgan Stanley: What To Like In Salesforce's Q1